Fenofibrate(160mg)+ Rosuvastatin(10mg) in pregnancy: classified as Category C. Fenofibrate(160mg)+ Rosuvastatin(10mg) pregnancy safety: Category C - Use with caution. Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to deter

Pregnancy SafetyUse With CautionFDA Cat. CAI-Verified

Is Fenofibrate(160mg)+ Rosuvastatin(10mg) safe during pregnancy?

Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to determine a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. In animal reproduction studies, no evidence of embryo-fetal toxicity was observed with oral administration of fenofibrate in rats and rabbits during organogenesis at doses less than or comparable to the maximum recommended clinical dosage of 145 mg of fenofibrate tablets daily, based on body surf...

SAFECAUTIONAVOID

Overall verdict

Use With Caution

Trimester-by-Trimester Guide

40 weeks · 3 stages · different risks

AVOID
AVOID
AVOID
Week 1
Week 13
Week 27Week 40
Avoid

1st Trimester

Weeks 1-12 · Organs forming

Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to determine a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. In animal reproduction studies, no evidence of embryo-fetal toxicity was observed with oral administration of fenofibrate in rats and rabbits during organogenesis at doses less than or comparable to the maximum recommended clinical dosage of 145 mg of fenofibrate tablets daily, based on body surf...

Avoid

2nd Trimester

Weeks 13-26 · Baby growing

Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to determine a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. In animal reproduction studies, no evidence of embryo-fetal toxicity was observed with oral administration of fenofibrate in rats and rabbits during organogenesis at doses less than or comparable to the maximum recommended clinical dosage of 145 mg of fenofibrate tablets daily, based on body surf...

Avoid

3rd Trimester

Weeks 27-40 · Final development

Risk Summary Limited available data with fenofibrate use in pregnant women are insufficient to determine a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. In animal reproduction studies, no evidence of embryo-fetal toxicity was observed with oral administration of fenofibrate in rats and rabbits during organogenesis at doses less than or comparable to the maximum recommended clinical dosage of 145 mg of fenofibrate tablets daily, based on body surf...

C

Category C - Use Cautiously

Animal studies show adverse effects; weigh benefits vs. risks.

Brands Available in India

Fenofibrate(160mg)+ Rosuvastatin(10mg) is sold under these common brand names. All contain the same active ingredient, so safety during pregnancy is identical. Tap any brand for detailed info.

advastat f strip of 10 tablets
AI-Verified · Based on FDA classifications + peer-reviewed sources

Not medical advice

Every pregnancy is different. Always consult your obstetrician before taking any medicine. Drug safety classifications can change — verify current guidelines with your doctor. For emergencies, call 112.

Frequently Asked Questions

Mom-to-be AI · 90+ languages

Pregnancy specific sawaal? AI se directly pooch lo.

Fenofibrate(160mg)+ Rosuvastatin(10mg) dose, safer alternatives, trimester-specific guidance — apni language mein.

Ask Health AI

This is 50% of what GoDavaii AI shows.

Personalized Fenofibrate(160mg)+ Rosuvastatin(10mg) pregnancy-safety review - trimester-specific dose, FDA category explained, safer alternatives - checked against YOUR pregnancy profile.

More Pregnancy Safety Guides

Ask AI